Concepedia

Hironori Ishigami

HI

Statistics

Publications

46

Citations

2.5K

H-Index

25

Active since

1999

Affiliations

The University of Tokyo(Current)

University of Tokyo Hospital

Jichi Medical University

Niigata Cancer Center Hospital

Nagoya University

Hironori Ishigami is an author at The University of Tokyo specializing in medicine, oncology, and chemotherapy.

ORCID

Publications per year

1999–2023

46

Publications

46

Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial

Hironori Ishigami, Yoshiyuki Fujiwara, Ryoji Fukushima et al. · Journal of Clinical Oncology · 2018 · 356 citations

, , +13

Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis

Hironori Ishigami, Joji Kitayama, Shoichi Kaisaki et al. · Annals of Oncology · 2009 · 232 citations · Full text

, , +17

Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination

Shigenobu Emoto, Hironori Ishigami, Hiroharu Yamashita et al. · Gastric Cancer · 2011 · 184 citations

, , +14

A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S‐1 for treatment of gastric cancer with macroscopic peritoneal metastasis

Hironori Yamaguchi, Joji Kitayama, Hironori Ishigami et al. · Cancer · 2013 · 124 citations

, , +15

Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings

Hironori Ishigami, Hironori Yamaguchi, Hiroharu Yamashita et al. · Gastric Cancer · 2016 · 115 citations · Full text

, , +17

1–5 of 46